Literature DB >> 7944295

Trinucleotide repeat length and rate of progression of Huntington's disease.

S N Illarioshkin1, S Igarashi, O Onodera, E D Markova, N N Nikolskaya, H Tanaka, T Z Chabrashwili, N G Insarova, K Endo, I A Ivanova-Smolenskaya.   

Abstract

The Huntington's disease gene contains an expanded unstable (CAG)n repeat, and the repeat lengths have been shown to correlate with the age of onset. Using detailed clinical scales, we evaluated the rate of progression of Huntington's disease and its relationship to the number of triplet repeats. We found significant positive correlation between the rate of progression of clinical symptoms (both neurological and psychiatric) and CAG repeat length. These data suggest an important role of expanded trinucleotide repeat length in affecting the pathological process during the entire course of Huntington's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944295     DOI: 10.1002/ana.410360412

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

Review 1.  Huntington disease--another chapter rewritten.

Authors:  M A Nance
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Differences in duration of Huntington's disease based on age at onset.

Authors:  T Foroud; J Gray; J Ivashina; P M Conneally
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

Review 3.  The genetic defect causing Huntington's disease: repeated in other contexts?

Authors:  J F Gusella; F Persichetti; M E MacDonald
Journal:  Mol Med       Date:  1997-04       Impact factor: 6.354

Review 4.  Molecular mechanisms of amyloid formation in living systems.

Authors:  Tessa Sinnige
Journal:  Chem Sci       Date:  2022-05-17       Impact factor: 9.969

5.  Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.

Authors:  N Masuda; J Goto; N Murayama; M Watanabe; I Kondo; I Kanazawa
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

6.  Survival of Huntington's disease patients in Serbia: longer survival in female patients.

Authors:  Tatjana Pekmezovic; Marina Svetel; Jelena Maric; Irena Dujmovic-Basuroski; Natasa Dragasevic; Milica Keckarevic; Stanka Romac; Vladimir S Kostic
Journal:  Eur J Epidemiol       Date:  2007-07-25       Impact factor: 8.082

7.  Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease.

Authors:  I Vuillaume; P Vermersch; A Destée; H Petit; B Sablonnière
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

8.  Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease.

Authors:  Branduff McAllister; James F Gusella; G Bernhard Landwehrmeyer; Jong-Min Lee; Marcy E MacDonald; Michael Orth; Anne E Rosser; Nigel M Williams; Peter Holmans; Lesley Jones; Thomas H Massey
Journal:  Neurology       Date:  2021-03-25       Impact factor: 11.800

9.  QEEG Measures in Huntington's Disease: A Pilot Study.

Authors:  Aimee Hunter; Yvette Bordelon; Ian Cook; Andrew Leuchter
Journal:  PLoS Curr       Date:  2010-10-25

10.  Instability of (CTG)n•(CAG)n trinucleotide repeats and DNA synthesis.

Authors:  Guoqi Liu; Michael Leffak
Journal:  Cell Biosci       Date:  2012-02-27       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.